Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C032668 |
1-nitropyrene |
1-nitropyrene results in increased expression of CCL20 mRNA | increases expression | 19879285
|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of CCL20 mRNA | increases expression | 19933214
|
C030682 |
3-chlorophenol |
3-chlorophenol results in increased expression of CCL20 mRNA | increases expression | 18486366
|
C033643 |
3-nitrofluoranthene |
3-nitrofluoranthene results in increased expression of CCL20 mRNA | increases expression | 19879285
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of CCL20 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CCL20 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in decreased expression of CCL20 mRNA | decreases expression | 16835338
|
C006632 |
arsenic trioxide |
[arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL20 mRNA | affects cotreatment|increases expression | 19828696
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of CCL20 mRNA | increases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CCL20 mRNA | increases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CCL20 mRNA | increases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of CCL20 mRNA | decreases expression | 16002434
|
D004391 |
Dust |
Dust results in increased expression of CCL20 mRNA | increases expression | 17805423
|
D004958 |
Estradiol |
Estradiol results in decreased expression of CCL20 mRNA | decreases expression | 16298037
|
D004958 |
Estradiol |
Estradiol results in increased expression of CCL20 mRNA | increases expression | 20106945
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of CCL20 mRNA | increases expression | 18035473
|
C070081 |
fulvestrant |
fulvestrant results in increased expression of CCL20 mRNA | increases expression | 16298037
|
C056507 |
gemcitabine |
gemcitabine results in increased expression of CCL20 mRNA | increases expression | 17039268
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene results in increased expression of CCL20 mRNA | increases expression | 15159207
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of CCL20 mRNA | increases expression | 15958647
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CCL20 mRNA | increases expression | 15860229
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in decreased expression of CCL20 mRNA | decreases expression | 17616710
|
D010126 |
Ozone |
Ozone results in increased expression of CCL20 mRNA | increases expression | 17095637 18417511
|
D010457 |
Peptidoglycan |
Peptidoglycan results in increased expression of CCL20 mRNA | increases expression | 15860229
|
D010457 |
Peptidoglycan |
Peptidoglycan results in increased expression of CCL20 protein | increases expression | 15191912
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CCL20 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCL20 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D020849 |
Raloxifene |
Raloxifene affects the expression of CCL20 mRNA | affects expression | 14699072
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in increased expression of CCL20 mRNA | affects cotreatment|increases expression | 19059307
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in increased expression of CCL20 mRNA | affects cotreatment|increases expression | 19059307
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of CCL20 mRNA | decreases expression | 16298037
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CCL20 mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CCL20 mRNA | increases expression | 19933214
|
D014212 |
Tretinoin |
[arsenic trioxide co-treated with Tretinoin] results in increased expression of CCL20 mRNA | affects cotreatment|increases expression | 19828696
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CCL20 mRNA | increases expression | 19828696
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CCL20 protein | increases expression | 19828696
|
D015054 |
Zymosan |
Zymosan results in increased expression of CCL20 protein | increases expression | 15191912
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.28 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.59 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.30 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.23 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.23 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.63 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.63 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.63 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
9.63 | 10697514 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.50 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.02 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.02 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
4.95 | 17306315 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.34 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.41 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.16 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.16 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.24 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
8.24 | 18664788 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.82 | 19183758 |
MESH:D020261 |
Arsenic Poisoning |
marker/mechanism |
|
| 16835338 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.79 | 12569548 16251483 18414634 16835338 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.21 | 16412693 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
7.21 | 15142272 15188379 15944321 16872482 17659584 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.45 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.45 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
4.67 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.67 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.10 | 12928151 19371607 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.60 | 11514358 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.15 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
20.01 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
20.01 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
20.01 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
20.01 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.52 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.60 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.22 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.13 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 16298037 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
7.99 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
7.99 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
7.99 | 14630087 18497071 17018787 19861407 12948864 17261762 17289903 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
7.99 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
7.99 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
7.99 | 18382427 17039268 |
MESH:D001943 |
Breast Neoplasms |
|
Hexachlorobenzene |
7.99 | 15061365 12709520 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
7.99 | 17242785 17952589 17049068 17261762 17440819 16912660 17595753 15572757 16837676 17893378 15775269 15758505 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
7.99 | 18629630 19059307 20065188 17261762 18855134 19066611 20005174 19011961 18425577 20859285 16202921 17049068 19103187 19288272 19142967 16873071 19289846 19200415 18984771 17893378 15565566 18997820 19115204 16273361 11161223 18821012 19221464 19487384 18351453 16818667 19155303 17440819 20544844 21138602 20135344 19410462 15668708 19244106 21152245 19189212 17242785 20390343 19084267 18815881 19189210 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
7.99 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
7.99 | 16166294 16443354 16873071 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.47 | 17626835 18417511 19059883 16777450 14754758 18315731 15516495 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.33 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.09 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.48 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.20 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.59 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.45 | 15504454 17687452 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.25 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.89 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
13.39 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
13.39 | 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
13.39 | 16217749 15553829 15073043 14691202 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
13.39 | 17159502 16270382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.39 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.39 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.61 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.89 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
13.50 | 18922899 15504454 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
13.50 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
13.50 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
13.50 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.50 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
14.60 | 18640142 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
14.60 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
14.60 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.22 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
6.96 | 17938729 15738583 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.96 | 15775269 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.09 | 16973168 18022660 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.94 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
5.98 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
5.98 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
12.10 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
12.10 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.94 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.12 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.12 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.89 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.40 | 12621046 8697196 15340226 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.40 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.36 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.45 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.73 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.73 | 17273769 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.93 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.59 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.59 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.59 | 9125849 8800419 9664655 10589399 14991402 17551590 9142499 16925845 9224671 9211117 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.85 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.10 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.94 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.61 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.75 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
13.75 | 15920148 17308373 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.75 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.47 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.57 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
14.56 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
14.56 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
14.56 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Zymosan |
14.56 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.05 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.05 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
14.00 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
14.00 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.00 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.44 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.44 | 17893378 16202921 20544844 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.44 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.80 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.13 | 15328337 15821434 17637181 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.89 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.89 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
6.89 | 16805852 15264214 15547721 15623463 16704527 16510608 15878914 15150132 15547733 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.19 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.19 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
22.15 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.15 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
22.15 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
22.15 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
22.15 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.08 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.20 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.79 | 9205823 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.26 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.92 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.22 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.22 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
13.22 | 17994277 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.29 | 6392382 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.01 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.95 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
6.88 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.88 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.33 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.01 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.89 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.29 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.29 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.29 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.36 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.38 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.16 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.16 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.10 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.45 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.41 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.41 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.76 | 15709030 |
MESH:D051677 |
Histiocytoma, Malignant Fibrous |
|
1-nitropyrene |
6.94 | 6692400 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.49 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.78 | 8697196 18606429 16959395 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.01 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.31 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.96 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.23 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
11.54 | 16076760 9931084 11953799 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.54 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
11.54 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.54 | 18850075 18670907 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.29 | 16093927 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
3.58 | 11514358 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
14.42 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
14.42 | 17237260 17963957 9205823 17255318 12878042 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
14.42 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.42 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Zymosan |
14.42 | 8014878 11289658 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.63 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.63 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.51 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.39 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.57 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.15 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.15 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.17 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.73 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.44 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.44 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.15 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.15 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.15 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.25 | 16973256 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.90 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.90 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.56 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.04 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.24 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
8.69 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.69 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.71 | 16467208 17050201 16968895 20471514 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.71 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
11.79 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
11.79 | 16112521 17649720 19075265 19225113 11468182 15213294 17107899 11161223 16823087 15622746 19035177 17217047 9834237 16966277 15336539 17869043 16331271 12018890 19642359 12679006 15748426 16891316 12712474 16330433 17712046 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
11.79 | 19225113 16140955 16788101 17107899 19075265 17339181 19029980 17217047 16766008 19642359 17506722 16891316 16331271 17712046 17301526 17649720 15748426 19035177 16935935 17294898 12679006 16823087 17368321 9834237 17361223 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.10 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.43 | 15821434 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.78 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.12 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.97 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.28 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
8.28 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.28 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.28 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.28 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.28 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.48 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
20.34 | 2125692 15890375 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
20.34 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
20.34 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
20.34 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
20.34 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
20.34 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.34 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
12.83 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
12.83 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Hexachlorobenzene |
12.83 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.83 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.15 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.20 | 8266340 19066396 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
13.76 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
13.76 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Ozone |
13.76 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
10.17 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
10.17 | 17306315 19168569 17976673 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
10.17 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
10.17 | 20464547 6695378 18569708 18520028 18816296 20135361 20064080 20869020 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
10.17 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
10.17 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
10.17 | 11884234 19555203 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.50 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
1-nitropyrene |
13.02 | 6692400 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.02 | 11408345 16891317 11807958 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
13.02 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
13.02 | 16827153 11731420 19196723 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.76 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.76 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.68 | 17453147 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
4.91 | 16270382 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.91 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.91 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.92 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.17 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.08 | 16966607 18303189 16166281 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.52 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.84 | 10496685 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.29 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.12 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
8.12 | 16274795 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
6.80 | 14977855 11468182 19417148 19549372 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
6.80 | 16497877 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.96 | 10479408 17724436 10890648 15259001 12879239 15213630 15241586 18160304 12130978 15834315 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.25 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.41 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.89 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.89 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.03 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
8.32 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.32 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.59 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.59 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.29 | 16343187 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.71 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.44 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.43 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
10.80 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
10.80 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.80 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.80 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.73 | 19189210 19200415 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.47 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.17 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.06 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.88 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.88 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.88 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
11.21 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
11.21 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.21 | 9142499 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.13 | 17056641 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.41 | 16303764 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.75 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.24 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.98 | 15758505 15579764 17823083 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
14.08 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
14.08 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.08 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
14.08 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.08 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.70 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
11.63 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
11.63 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
11.63 | 11504793 18992248 17440100 16929163 18383843 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.63 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.92 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.98 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
3.93 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.73 | 15371236 6392382 16905509 |
MESH:D010538 |
Peritonitis |
|
Ozone |
9.55 | 16369182 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
9.55 | 18557954 11985352 19641140 18760300 19088179 15259001 17826846 18977430 15979727 17371808 14761945 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.63 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
10.22 | 12224865 11605937 |
MESH:D011014 |
Pneumonia |
|
Ozone |
10.22 | 18007984 18381685 18929643 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Hexachlorobenzene |
10.27 | 9918132 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
10.27 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.00 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.93 | 11896295 11222880 11118676 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.52 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.65 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.40 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.40 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.40 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.40 | 12479363 18247401 16644109 15754350 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.40 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.40 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.40 | 15731164 16220300 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.40 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
8.47 | 21343184 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
8.47 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.14 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.53 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.93 | 15814490 17322281 17975199 17365031 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.29 | 15770314 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.26 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.56 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.59 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.21 | 16303925 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.86 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.71 | 16646077 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.44 | 11441115 |
MESH:D012871 |
Skin Diseases |
marker/mechanism |
|
| 16835338 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.68 | 17050553 16759981 17453740 18709164 17938729 16702368 16353154 15952646 19834688 17548696 6392382 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
16.61 | 19538983 17029826 17050553 17976673 16251483 15504454 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
16.61 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
16.61 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.61 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
16.61 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.03 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.78 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
4.50 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.50 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
4.50 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.50 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.62 | 16837676 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.94 | 15821434 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.64 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
6.55 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.55 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.82 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.82 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.56 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.70 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.07 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
18.53 | 19429237 11144890 15987713 17976673 18640142 19322015 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
18.53 | 12845720 12973940 20435036 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
18.53 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
18.53 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
18.53 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
18.53 | 8653321 17572228 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
8.95 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.95 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.34 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
11.09 | 1336536 |
MESH:D014605 |
Uveitis |
|
Zymosan |
11.09 | 11006244 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.47 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.33 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.94 | 16837676 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.81 | 16761959 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.29 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.98 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.75 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.17 | 17120751 |